Clinical Trial

Clinical Study to Determine Bioequivalence of Oral Tamsulosin Products as 0.4 mg Prolonged-release Tablets in Male Subjects Under Fed Conditions

Name: Clinical Study to Determine Bioequivalence of Oral Tamsulosin Products as 0.4 mg Prolonged-release Tablets in Male Subjects Under Fed Conditions — clinical trial record (NCT07698288)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ACL25-PC007

Completed

View on ClinicalTrials.gov →

Summary

Prospective, longitudinal, single-dose, randomized, open-label, crossover 2x4, replicated, two treatments, four periods, two sequences controlled clinical study

Trial Details

NCT Number	NCT07698288
Lead Sponsor	ADIUM
Conditions	Bioequivalence
Enrollment	66 participants
Start Date	2026-02-12
Primary Completion	2026-04-16 (estimated)
Study Completion	2026-04-16 (estimated)
Updated on ClinicalTrials.gov	2026-07-13